Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
New and emerging immune-targeted drugs for the treatment of multiple sclerosis.
Melatonin treatment improves primary progressive multiple sclerosis: a case report.
Multiple sclerosis: Managing patients in primary care.
Assessment set for evaluation of clinical outcomes in multiple sclerosis: psychometric properties.
Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.
Brain ageing and disorders of the central nervous system: kynurenines and drug metabolism.
In vivo immunomodulatory effect of the lectin from edible mushroom Agaricus bisporus.
Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
Activation-induced cell death in T lymphocytes from multiple sclerosis patients.
Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability.
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.
Constraint-induced movement therapy: a method for harnessing neuroplasticity to treat motor disorders.
Smoking as a risk factor for multiple sclerosis.
Reading, writing, and reserve: Literacy activities are linked to hippocampal volume and memory in multiple sclerosis.
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
Neurovascular and Immuno-Imaging: From Mechanisms to Therapies. Proceedings of the Inaugural Symposium.
Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis.
Safety and efficacy of reduced fingolimod dosage treatment.
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects.
First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm.
Deficiency of IκB Kinase β in Myeloid Cells Reduces Severity of Experimental Autoimmune Encephalomyelitis.
The Relationship between Specific Cognitive Domains, Fear of Falling, and Falls in People with Multiple Sclerosis.
African ancestry is a predictor factor to secondary progression in clinical course of multiple sclerosis.
Use of an early disease-modifying drug adherence measure to predict future adherence in patients with multiple sclerosis.
Pages
« first
‹ previous
…
390
391
392
393
394
395
396
397
398
…
next ›
last »